(Q84381375)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Recommendations for neonatal surfactant therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

Paediatrics & Child Health

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

109-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation

5 February 2020

cites work

1 reference

12 December 2020

Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa

1 reference

12 December 2020

Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH.

1 reference

12 December 2020

Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant

1 reference

12 December 2020

Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial)

1 reference

12 December 2020

Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA

1 reference

12 December 2020

Randomized study of nasal continuous positive airway pressure in the preterm infant with respiratory distress syndrome.

1 reference

12 December 2020

Surfactant replacement therapy in high-risk congenital diaphragmatic hernia

1 reference

12 December 2020

Surfactant replacement therapy for meconium aspiration syndrome

1 reference

12 December 2020

Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study

1 reference

12 December 2020

Pulmonary pathology in surfactant-treated preterm infants with respiratory distress syndrome: an autopsy study

1 reference

12 December 2020

Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment

1 reference

12 December 2020

Principles of surfactant replacement

1 reference

12 December 2020

Cost effectiveness of beractant in the prevention of respiratory distress syndrome

1 reference

12 December 2020

High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome

1 reference

12 December 2020

Surfactant therapy prior to the interhospital transport of preterm infants.

1 reference

12 December 2020

Immunologic consequences of exogenous surfactant administration

1 reference

12 December 2020

Sequential changes in compliance and resistance after bolus administration or slow infusion of surfactant in preterm infants.

1 reference

12 December 2020

Surfactant replacement: immunological considerations

1 reference

12 December 2020

Safety of synthetic surfactant use before preterm newborn transport

1 reference

12 December 2020

Economic outcome for intensive care of infants of birthweight 500-999 g born in Victoria in the post surfactant era. The Victorian Infant Collaborative Study Group

1 reference

12 December 2020

Surfactant replacement therapy in neonates with respiratory failure due to bacterial sepsis

1 reference

12 December 2020

Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial

1 reference

12 December 2020

Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome

1 reference

12 December 2020

Neonatal pulmonary ischemia. I. Clinical and physiological studies

1 reference

12 December 2020

Acute side effects of surfactant treatment

1 reference

12 December 2020

Immunogenicity and immunomodulatory activity of bovine surfactant (SF-RI 1)

1 reference

12 December 2020

Cost effects of surfactant therapy for neonatal respiratory distress syndrome

1 reference

12 December 2020

High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity

1 reference

12 December 2020

Surfactant treatment of full-term newborns with respiratory failure

1 reference

12 December 2020

Appropriate positive end expiratory pressure level in surfactant-treated preterm infants

1 reference

12 December 2020

Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.

1 reference

12 December 2020

Exogenous surfactant therapy in newborns.

1 reference

12 December 2020

A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome.

1 reference

12 December 2020

Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis

1 reference

12 December 2020

Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome

1 reference

12 December 2020

Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage

1 reference

12 December 2020

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

1 reference

12 December 2020

Extensive intraalveolar pulmonary hemorrhage in infants dying after surfactant therapy

1 reference

12 December 2020

Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group

1 reference

12 December 2020

Surfactant replacement therapy in preterm neonates: a comparison of postmortem pulmonary histology in treated and untreated infants

1 reference

12 December 2020

Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf

1 reference

12 December 2020

Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease

1 reference

12 December 2020

MICROAEROSOL ADMINISTRATION OF SYNTHETIC BETA-GAMMA-DIPALMITOYL-L-ALPHA-LECITHIN IN THE RESPIRATORY DISTRESS SYNDOME: A PRELIMINARY REPORT

1 reference

12 December 2020

Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants

1 reference

12 December 2020

Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. Survanta Multidose Study Group

1 reference

12 December 2020

Surfactant and surfactant inhibitors in meconium aspiration syndrome.

1 reference

12 December 2020

Natural vs synthetic surfactants in neonatal respiratory distress syndrome

1 reference

12 December 2020

Assisted ventilation and survival of extremely low birthweight infants

1 reference

12 December 2020

Antenatal corticosteroid therapy for fetal maturation.

1 reference

12 December 2020

Immune response after surfactant treatment of newborn infants with respiratory distress syndrome

1 reference

12 December 2020

Dextran reduces surfactant inhibition by meconium

1 reference

12 December 2020

Improved outcome of preterm infants when delivered in tertiary care centers

1 reference

12 December 2020

Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial

1 reference

12 December 2020

Overcoming surfactant inhibition with polymers

1 reference

12 December 2020

Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group

1 reference

12 December 2020

Surfactant. Evolving issues

1 reference

12 December 2020

Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation

1 reference

12 December 2020

Surface properties in relation to atelectasis and hyaline membrane disease.

1 reference

12 December 2020

Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome

1 reference

12 December 2020

Overview of clinical trials comparing natural and synthetic surfactants

1 reference

12 December 2020

Variations in antenatal corticosteroid therapy: a persistent problem despite 30 years of evidence.

1 reference

12 December 2020

Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.

1 reference

12 December 2020

Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668609%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

19668609

1 reference